T1DM is commonly preceded by a pre-clinical phase of islet autoimmunity (IA), defined by the presence of circulating glutamic acid decarboxylase, insulin and protein tyrosine phosphatase-2 autoantibodies. This evidence concerns the gene INS and type 1 diabetes mellitus.